Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Evaporation Chemistry at ACS

Published: Monday, August 19, 2013
Last Updated: Monday, August 19, 2013
Bookmark and Share
Genevac to display its latest products for productive evaporation in USA.

Genevac has announced that it will display its latest products for productive evaporation at the 246th American Chemical Society meeting and exposition in Indianapolis, Indiana, USA (8th - 12th September 2013).Genevac_PN.gif

Visitors to Booth 2017 will have the chance to see for the first time the ROCKET 4D - a new fully automated system for drying or concentration of very large volumes (a few to 100 litres) in one operation with no user interaction.

Simply load sample, select a method, press start, and walk away - the system will do the rest.

Compact in size the ROCKET 4D allows users to safely dry or concentrate their samples with complete confidence as it uses proprietary vacuum technology to suppress solvent bumping and foaming - problems associated with sample loss when using large scale rotary evaporators.

To download a ROCKET 4D technical brochure, please visit www.genevac.com/Rocket4D.

Specialists will also be on hand to demonstrate and discuss the third generation EZ-2 Series Evaporator - an easy-to-use benchtop system that uses the most advanced proven technology in evaporation science.

The EZ-2 accurately controls vacuum and temperature to enable rapid evaporation of a wide range of solvents and prevent bumping and cross contamination.

Compatible with a wide range of sample holders the EZ-2 will easily integrate within the workflow of many laboratories. Options are available to enable routine, safe removal of potentially explosive solvents such as diethyl ether or pentane and also removal of acids including concentrated hydrochloric acid (HCl).

To download an EZ-2 technical brochure, watch a product video or download applications reports please visit - www.genevac.com/movie/ez2.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Designing Better Drugs
A rational drug engineering approach could breathe new life into drug development.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Factors Influencing Influenza Vaccine Effectiveness Uncovered
The long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited, new research suggests.
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
New Model to Enhance Zika Virus Research
The model will allow researchers to better understand how the virus causes disease and aid in the development of antiviral compounds and vaccines.
Improving Flu Vaccine Effectiveness
NIH study finds factors that may influence influenza vaccine effectiveness.
BMS’s Opdivo Clinical Trial Shows Promise
Safety profile of the combination regimen from CheckMate -069 was consistent with previously reported studies and adverse events were managed using established safety algorithms.
CNS Inflammation: A Pathway and Possible Drug Target
Scientists have long known that the central nervous system (CNS) has a remarkable ability to limit excessive inflammation in the presence of antigens or injury, but how it works has been unclear.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!